Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia.

TO THE EDITOR: Large granular lymphocytic (LGL) leukemia and myelodysplastic syndromes (MDSs) both typically present with unexplained cytopenias, yet these diseases are pathobiologically distinct and associated with substantial differences in prognosis and therapy. LGL leukemias, including both T-

• Publication year

  2017

• Venue

  Blood Advances

• Publication date

  2017-09-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/bloodadvances.2017011197PMID 29296824PMCID PMC5728102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation

  2017cited by this paper
• Clinical significance of somatic mutation in unexplained blood cytopenia.

  2017cited by this paper
• High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

  2016cited by this paper
• Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms

  2016cited by this paper
• Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.

  2016cited by this paper
• T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance.

  2016cited by this paper
• Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.

  2016cited by this paper
• Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia

  2015cited by this paper
• Next-Generation Sequencing-Based Panel Testing for Myeloid Neoplasms

  2015cited by this paper
• Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia.

  2014cited by this paper
• Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

  2014cited by this paper
• Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells

  2014cited by this paper
• Uncovering the pathogenesis of large granular lymphocytic leukemia—novel STAT3 and STAT5b mutations

  2014cited by this paper
• Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

  2013cited by this paper
• Clinical and biological implications of driver mutations in myelodysplastic syndromes.

  2013cited by this paper
• Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

  2013cited by this paper
• Distinguishing T-cell Large Granular Lymphocytic Leukemia from Reactive Conditions: Laboratory Tools and Challenges in Their Use.

  2013cited by this paper
• STAT3 mutations are highly specific for large granular lymphocytic leukemia

  2013cited by this paper
• STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.

  2013cited by this paper
• STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.

  2012cited by this paper
• Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors

  2012cited by this paper
• Somatic STAT3 mutations in large granular lymphocytic leukemia.

  2012cited by this paper
• Clinical effect of point mutations in myelodysplastic syndromes.

  2011cited by this paper
• T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases.

  2009cited by this paper
• Coincident myelodysplastic syndrome and T‐cell large granular lymphocytic disease: clinical and pathophysiological features

  2001cited by this paper

• Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.

  2024cites this paper
• Diagnosis and classification of myelodysplastic syndromes.

  2023cites this paper
• Persistent Large Granular Lymphocyte Clonal Expansions: “The Root of Many Evils”—And of Some Goodness

  2022cites this paper
• STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological dysregulation of NKG2Dhi CD8 killer T cells

  2022cites this paper
• STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+ T cell dysregulation and accumulation.

  2022cites this paper
• Molecular Features and Diagnostic Challenges in Alpha/Beta T-Cell Large Granular Lymphocyte Leukemia

  2022cites this paper
• Targeting the oncogenic signaling of the transcription factor STAT3 with potent and selective monobody inhibitors

  2020cites this paper
• Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia

  2020cites this paper
• Flow Cytometry Applications in the Diagnosis of T/NK‐Cell Lymphoproliferative Disorders

  2019cites this paper
• What is new in mature T-cell leukemias?

  2019cites this paper
• Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

  2019cites this paper
• Genomics of LGL leukemia and select other rare leukemia/lymphomas.

  2019influential citation
• How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.

  2018cites this paper